No Cover Image

Journal article 52 views

Sex differences in attention‐deficit hyperactivity disorder diagnosis and clinical care: a national study of population healthcare records in Wales

Joanna Martin Orcid Logo, Kate Langley Orcid Logo, Miriam Cooper Orcid Logo, Olivier Rouquette Orcid Logo, Ann John Orcid Logo, Kapil Sayal Orcid Logo, Tamsin Ford Orcid Logo, Anita Thapar Orcid Logo

Journal of Child Psychology and Psychiatry

Swansea University Authors: Olivier Rouquette Orcid Logo, Ann John Orcid Logo

  • 66081.VoR.pdf

    PDF | Version of Record

    Copyright: 2024 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License.

    Download (846KB)

Check full text

DOI (Published version): 10.1111/jcpp.13987

Abstract

BackgroundPopulation-based studies have observed sex biases in the diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD). Females are less likely to be diagnosed or prescribed ADHD medication. This study uses national healthcare records, to investigate sex differences in diagnos...

Full description

Published in: Journal of Child Psychology and Psychiatry
ISSN: 0021-9630 1469-7610
Published: Wiley 2024
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa66081
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: BackgroundPopulation-based studies have observed sex biases in the diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD). Females are less likely to be diagnosed or prescribed ADHD medication. This study uses national healthcare records, to investigate sex differences in diagnosis and clinical care in young people with ADHD, particularly regarding recognition and treatment of other mental health conditions.MethodsThe cohort included individuals diagnosed with ADHD, born between 1989 and 2013 and living in Wales between 2000 and 2019. Routine primary and secondary healthcare record data were used to derive diagnoses of ADHD and other neurodevelopmental and mental health conditions, as well as ADHD and antidepressant medications. Demographic variables included ethnicity, socioeconomic deprivation and contact with social services.ResultsThere were 16,458 individuals diagnosed with ADHD (20.3% females, ages 3–30 years), with a male-to-female ratio of 3.9:1. Higher ratios (4.8:1) were seen in individuals diagnosed younger (<12 years), with the lowest ratio (1.9:1) in those diagnosed as adults (>18). Males were younger at first recorded ADHD diagnosis (mean = 10.9 vs. 12.6 years), more likely to be prescribed ADHD medication and younger at diagnosis of co-occurring neurodevelopmental conditions. In contrast, females were more likely to receive a diagnosis of anxiety, depression or another mental health condition and to be prescribed antidepressant medications, prior to ADHD diagnosis. These sex differences were largely stable across demographic groups.ConclusionsThis study adds to the evidence base that females with ADHD are experiencing later recognition and treatment of ADHD. The results indicate that this may be partly because of diagnostic overshadowing from other mental health conditions, such as anxiety and depression, or initial misdiagnosis. Further research and dissemination of findings to the public are needed to improve awareness, timely diagnosis and treatment of ADHD in females.
Keywords: ADHD; sex differences; neurodevelopmental conditions; mental health
College: Faculty of Medicine, Health and Life Sciences
Funders: Brain and Behavior Research Foundation. Grant Number: 27879 Health and Care Research Wales. Grant Number: NIHR-FS(A)-2022